Skip to main content
. 2017 Sep 25;13(3):218–224. doi: 10.5114/aic.2017.70189

Table I.

Clinical and demographic characteristics of RPH patients according to treatment methods

Variable Conservative (n = 51) Stenting (n = 9) Surgery (n = 8) P-value
Gender Male 29 (56.9%) 6 (66.7%) 6 (75%) 0.569
Female 22 (43.1%) 3 (33.3%) 2 (25%)
Age 64.4 ±13.04 62.1 ±16.3 55.7 ±15.8 0.252
Comorbidities DM 18 (35.3%) 3 (33.3%) 2 (25%) 0.849
HT 27 (52.9%) 4 (44.4%) 2 (25%) 0.328
COPD 8 (15.7%) 0 3 (37.5%) 0.109
CRF 5 (9.8%) 1 (11.1%) 1 (12.5%) 0.970
CVD 5 (9.8%) 0 1 (12.5%) 0.587
AF 2 (3.9%) 2 (22.2%) 1 (12.5%) 0.128
Weight [kg] 80.63 ±10.94 74.44 ±9.4 78.13 ±10.96 0.270
BMI [kg/m2] 27.9 ±4.39 25.7 ±4.2 26.49 ±4.04 0.297
LVEF 55.2 ±6.8 53.89 ±10.8 53.75 ±13.02 0.840
Indication for PCI Acute MI 20 (39.2%) 1 (11.1%) 3 (37.5%) 0.716
Unstable angina 13 (25.5%) 3 (33.3%) 2 (25%)
Stable angina 11 (21.61%) 3 (33.3%) 1 (12.5%)
Valvular heart disease 5 (9.8%) 2 (22.2%) 1 (12.5%)
Right heart catheterization 2 (3.9%) 0 1 (12.5%)
PCI 33 (64.7%) 8 (88.9%) 5 (62.5%) 0.341

DM – diabetes mellitus, HT – hypertension, COPD – chronic obstructive pulmonary disease, CRF – chronic renal failure, CVD – cerebrovascular disease, AF – atrial fibrillation, BMI – body mass index, LVEF – left ventricle ejection fraction, MI – myocardial infarction, PCI – percutaneous coronary intervention.